The efficacy of triple drug combination in prevention of nausea and vomiting after surgery in adult patients undergoing laparoscopic surgries.
Phase 2
Completed
- Conditions
- Health Condition 1: K768- Other specified diseases of liver
- Registration Number
- CTRI/2022/11/047333
- Lead Sponsor
- Mythreyee Ganti
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 70
Inclusion Criteria
Adults of American society of Anaesthesiology physical status I/II aged 18 to 60 years undergoing laparoscopic surgeries
Exclusion Criteria
1. Patients already on treatment with anti-emetics, steroid medication,or any other drug known to cause emesis currently or in the immediate past
2.Patients with known hypersensitivity to Aprepitant, Ramosetron or Dexamethasone
3.Pregnant or nursing mothers
4.Hepatic, renal or cardiac insufficiency
5.Vomiting within 24 hours before surgery or of any organic etiology
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method